KALA
Kala Bio, Inc.
A biopharmaceutical company developing treatments for eye diseases, best known for EYSUVIS, an eye drop approved to treat inflammation and pain after eye surgery. The company, founded in 2009 as Kala Pharmaceuticals and renamed Kala Bio, also developed Inveltys for ocular inflammation. Its name was inspired by the medical journal of the American Academy of Ophthalmology, which in early years was called "Kala" — a nod to the field it serves.
CUSIP: 483119103HealthcareUS1 holder
Total Value
$211.0K
Total Shares
80.4K
Net Share Change
-1.2K
Activity
1 selling
Investor
Value
Shares
Weight
Change
